The "gI dissolution" method: A low volume, in vitro apparatus for assessing the dissolution/precipitation behaviour of an active pharmaceutical ingredient under biorelevant conditions

Analytical Methods

Volumn 3, Issue 3, 2011, Pages 560-567

  Gravestock, Tom ^a   Box, Karl ^a   Comer, John ^a   Frake, Elizabeth ^a   Judge, Sam ^a   Ruiz, Rebeca ^a  

^a Sirius Analytical Instruments Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE PHARMACEUTICAL INGREDIENTS; DRUG COMPOUNDS; EXPERIMENTAL CONDITIONS; GASTROINTESTINAL TRACT; IN-VITRO; PH CONTROL; PHYSIOLOGICAL CONDITION; PRECIPITATION BEHAVIOUR;

DRUG PRODUCTS;

DISSOLUTION;

EID: 79952941668     PISSN: 17599660     EISSN: 17599679     Source Type: Journal    
DOI: 10.1039/c0ay00434k     Document Type: Article

References (28)

1. C. B. Pheatt J. Qual. Tech. 1980 12 158 164
2. Dissolution Testing of Solid Oral Dosage Forms, British Pharmacopoeia, The Stationery Office, London, 2002, pp. A419-A421
3. U. V. Banakar and M. C. Makoid, Drug Dissolution and Bioavailability, Technomic Publishing Company, Lancaster, PA, 1994
4. Dissolution, United States Pharmacopeia 23, Rockville, MD, United States Pharmacopeial Convention, 1995a, pp. 1791-1793
5. In Vitro and In Vivo Evaluation of Dosage Forms, United States Pharmacopeia 23, United States Pharmacopeial Convention, Rockville, MD, 1995b, pp. 1924-1929
6. J. E. Loske Drug Inf. J. 1993 27 463 468
7. V. A. Gray Dissolution Technol. 2002 9 1 1 4
8. R. L. Williams T. S. Foster Dissolution Technol. 2004 11 3 6 7
9. J. B. Dressman Dissolution Technol. 2004 11 3 8 9
10. V. P. Shah Dissolution Technol. 2004 11 3 11
11. V. A. Gray Dissolution Technol. 2004 11 3 13 14
12. Extended Release Oral Dosage Forms; Development, Evaluation and Application of In Vitro/In Vivo Correlations, Guidance for Industry, Food and Drug Administration, Rockville, MD, 1997
13. H. J. Malinowski, in Advances in Experimental Medicine and Biology, In Vitro-In Vivo Correlations, ed., D. Young,,, J. Devane, and, J. Butler,, Plenum, New York, 1997, vol. 423, pp. 261-268
14. Immediate Release Solid Oral Dosage Forms. Scale-up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation, Guidance for industry, Food and Drug Administration, Rockville, MD, 1995
15. Modified Release Solid Oral Dosage Forms. Scale-up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation, Guidance for Industry, Food and Drug Administration, Rockville, MD, 1997
16. J. P. Skelly G. F. Shiu Eur. J. Drug Metab. Pharmacokinet. 1993 18 121 129
17. Note for Guidance on Quality of Modified Release Products: A: Oral Dosage Forms B: Transdermal Dosage Forms Section I (Quality), European Agency for the Evaluation of Medicinal Products, London, 1999
18. J. P. Skelly G. L. Amidon W. H. Barr L. Z. Benet J. E. Carter J. R. Robinson V. P. Shah A. Yacobi Pharm. Res. 1990 7 975 982
19. R. Lobenberg G. L. Amidon Eur. J. Pharm. Biopharm. 2000 50 3 12
20. K. Box J. Comer T. Gravestock Chem. Biodiversity 2009 6 1767 1788
21. K. G. Mooney M. A. Mintun K. J. Himmelstein V. J. Stella J. Pharm. Sci. 1981 70 13 22
22. G. L. Amidon A. S. Carlin A. S. Hussain L. X. Yu Int. J. Pharm. 2004 270 221 227
23. T. X. Viegas R. U. Curatella L. L. VanWinkle G. Brinker Pharm. Technol. 2001 25 44 53
24. W. W. Hauck A. J. DeStefano W. E. Brown E. S. Stippler D. R. Abernethy R. L. Williams Dissolution Technol. 2009 16 1 7 12
25. J. Mauger J. Ballard R. Brockson S. De V. Gray D. Robinson Dissolution Technol. 2003 10 3 6 15
26. A. Avdeef O. Tsinman Pharm. Res. 2008 25 2613 2626
27. M. Marques Dissolution Technol. 2004 11 2 16
28. E. Baka K. Box J. Comer K. Takács-Novák G. Völgyi Anal. Chim. Acta 2010 673 1 40 46